Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Myelofibrosis · Myelofibrosis; Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
Contact: Study coordinator (Angela Fleischman, MD, PhD) · ucstudy@uci.edu · 877-827-8839

Study leads

Angela Flesichman, MD, PhD
Principal Investigator
Chao Family Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Myelofibrosis; Anemia · Anemia · Myelofibrosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Duarte, United States

A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Fuzhou, China

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States · Basking Ridge, United States

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

Splenomegaly · Myelofibrosis

Abroad (travel likely)RecruitingPHASE2

Houston, United States